A South African natural gas company, Renergen, is using its knowledge of cryogenics to develop an ultra-cold biological transport freezer prototype, CryoVacc.
The freezer was created to maintain constant internal temperatures of between 8 to -150 C for more than 25 days — and without needing external power sources.
With billions of people who will most likely need around two doses of the coronavirus vaccines to attain global herd immunity, a vaccine rollout in these hard-to-reach areas could be a logistics nightmare in this unprecedented health crisis.
Marani touts CryoVacc as a viable option to overcome potential transportation and storage issues.
Perhaps a game-changer as the United Nations called for a coordinated global effort to vaccinate against coronavirus – warning that gaping inequities in initial efforts put the whole planet at risk.
Secretary-General Antonio Guterres also made mention of the fact that just 10 nations have administered 75% of doses so far while 130 countries have had none at all.
